Delivery Order SPE2DB25D2204-SPE2DB25FTGXB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,128.85 to AmerisourceBergen Drug Corp for the supply of Sunosi 150 mg tablets (30-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Sunosi 150 mg tablets (30-count packaging) valued at $1,013.56. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion master agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,141.29 to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Sunosi 150 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is scheduled for ultimate completion on July 9, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,176.94 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SUNOSI (solriamfetol) is a wakefulness-promoting agent used to treat excessive daytime sleepiness in...
- The Defense Logistics Agency awarded a delivery order valued at $1,695.28 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on April 23, 2025, with an ultimate completion date of April 24, 2025. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing federal contract portfolio supporting military and...
- The Defense Logistics Agency awarded a $2,445.76 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count). This firm fixed-price contract represents a non-set-aside competitive award and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets in a quantity of 30 units, valued at $2,700.87. This competitive, non-set-aside contract was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, and utilizes firm fixed-price pricing. The award is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. Performance will occur at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $2,721.90 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Sunosi 75 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on July 17, 2025, for the supply of Sunosi 75 mg tablets (30-count units) with a ceiling value of $4,264.03. This non-set-aside contract represents a firm fixed price delivery order and is part of AmerisourceBergen's broader engagement with DLA's medical supply chain. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 18,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,792.60 to AmerisourceBergen Drug Corp for the supply of Sunosi (solriamfetol) 75 mg tablets in a 30-count package. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, and the place of...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGXBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,322.37 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price contract, placed through a non-set-aside competitive procurement, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical pharmaceutical distributor for federal medical procurement needs. This award reflects AmerisourceBergen's ongoing role as a primary vendor within the DLA's medical supply chain, supporting military and veteran healthcare systems through its $999,999,999.00 Indefinite Delivery Vehicle running through December 2026. SUNOSI (solriamfetol) is a wakefulness-promoting agent used to treat excessive daytime sleepiness associated with narcolepsy and other conditions, and this procurement demonstrates the company's capability to supply specialized pharmaceutical products across multiple therapeutic domains to support federal healthcare requirements. AmerisourceBergen's consistent receipt of competitively awarded delivery orders across diverse medication categories underscores its established position as a qualified supplier meeting DLA medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/18/25 |